Acumen Pharmaceuticals Inc
NASDAQ:ABOS
Income Statement
Earnings Waterfall
Acumen Pharmaceuticals Inc
Revenue
|
0
USD
|
Operating Expenses
|
-61.1m
USD
|
Operating Income
|
-61.1m
USD
|
Other Expenses
|
8.8m
USD
|
Net Income
|
-52.4m
USD
|
Income Statement
Acumen Pharmaceuticals Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
1
N/A
|
1
-16%
|
1
-12%
|
0
-69%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(9)
|
(11)
|
(12)
|
(13)
|
(20)
|
(25)
|
(32)
|
(39)
|
(45)
|
(49)
|
(52)
|
(57)
|
(61)
|
|
Selling, General & Administrative |
(1)
|
(2)
|
(3)
|
(5)
|
(7)
|
(9)
|
(11)
|
(12)
|
(13)
|
(14)
|
(15)
|
(17)
|
(19)
|
|
Research & Development |
(8)
|
(9)
|
(9)
|
(8)
|
(12)
|
(16)
|
(21)
|
(27)
|
(32)
|
(35)
|
(37)
|
(40)
|
(42)
|
|
Operating Income |
(8)
N/A
|
(10)
-22%
|
(11)
-14%
|
(13)
-13%
|
(20)
-57%
|
(25)
-28%
|
(32)
-28%
|
(39)
-23%
|
(45)
-15%
|
(49)
-9%
|
(52)
-6%
|
(57)
-9%
|
(61)
-7%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
6
|
8
|
9
|
|
Total Other Income |
1
|
(23)
|
(81)
|
(81)
|
(81)
|
(58)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Pre-Tax Income |
(7)
N/A
|
(32)
-341%
|
(92)
-184%
|
(93)
-2%
|
(101)
-8%
|
(83)
+18%
|
(32)
+62%
|
(38)
-22%
|
(43)
-12%
|
(45)
-5%
|
(47)
-3%
|
(49)
-5%
|
(52)
-7%
|
|
Net Income | ||||||||||||||
Income from Continuing Operations |
(7)
|
(32)
|
(92)
|
(93)
|
(101)
|
(83)
|
(32)
|
(38)
|
(43)
|
(45)
|
(47)
|
(49)
|
(52)
|
|
Net Income (Common) |
(7)
N/A
|
(32)
-341%
|
(92)
-184%
|
(93)
-2%
|
(101)
-8%
|
(83)
+18%
|
(32)
+62%
|
(38)
-22%
|
(43)
-12%
|
(45)
-5%
|
(47)
-3%
|
(49)
-5%
|
(52)
-7%
|
|
EPS (Diluted) |
-0.19
N/A
|
-0.83
-337%
|
-2.37
-186%
|
-2.43
-3%
|
-5.02
-107%
|
-2.04
+59%
|
-0.77
+62%
|
-0.94
-22%
|
-1.06
-13%
|
-1.1
-4%
|
-1.13
-3%
|
-0.89
+21%
|
-1.08
-21%
|